TLR6 p.Ser249Ala

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateB3_Supporting

The NM_006068.5(TLR6):c.745T>G (p.Ser249Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (no review stars).

Frequency

Genomes: not found (cov: 32)

Consequence

TLR6
NM_006068.5 missense

Scores

19

Clinical Significance

protective no assertion criteria provided B:1

Conservation

PhyloP100: 0.928

Publications

230 publications found
Variant links:
Genes affected
TLR6 (HGNC:16711): (toll like receptor 6) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006068.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_006068.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TLR6 NM_006068.5
MANE Select
HGVSc / HGVSpc.745T>Gp.Ser249Ala
Exon rankExon 2 of 2
missense
Prot: NP_006059.2
TLR6 NM_001394553.1
HGVSc / HGVSpc.745T>Gp.Ser249Ala
Exon rankExon 2 of 2
missense
Prot: NP_001381482.1UniProt: Q9Y2C9-1

Ensembl Transcripts

TLR6 ENST00000508254.6
TSL:1MANE Select
HGVSc / HGVSpc.745T>Gp.Ser249Ala
Exon rankExon 2 of 2
missense
Prot: ENSP00000424718.2UniProt: Q9Y2C9-1
TLR6 ENST00000381950.2
TSL:6
HGVSc / HGVSpc.745T>Gp.Ser249Ala
Exon rankExon 3 of 3
missense
Prot: ENSP00000371376.1UniProt: Q9Y2C9-1
TLR6 ENST00000966018.1
HGVSc / HGVSpc.745T>Gp.Ser249Ala
Exon rankExon 2 of 2
missense
Prot: ENSP00000636077.1UniProt: Q9Y2C9-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:49
GnomAD4 genome
Cov:32
Showing 3 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.0000238 141958 0.00 066886
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:protective
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Leprosy, susceptibility to, 1 (1)

Computational Scores

AlphaGenome AVI
Uncertain16
AlphaMissense
Benign0.077
BayesDel_addAF
Benign-0.25T
BayesDel_noAF
Benign-0.59
CADD
Benign5.2
DANN
Benign0.60
DEOGEN2
Benign0.080T
Eigen
Benign-1.3
Eigen_PC
Benign-1.2
FATHMM_MKL
Benign0.18N
FuncVEP CTI
Benign0.024
GPN-Star LLR
N/A0.37
GPN-Star score
N/A-0.37
LIST_S2
Benign0.47T
M_CAP
Benign0.0064T
MetaRNN
Benign0.046T
MetaSVM
Benign-0.98T
Mutation Taster
N/A99/1polymorphism
MutationAssessor
Benign0.49N
PhyloP100
Benign0.93
popEVE
Benign-2.9
PrimateAI
Benign0.27T
PROVEAN
Benign-0.42N
REVEL
Benign0.062
Sift
Benign1.0T
Sift4G
Benign0.78T
Varity_R
N/A0.021
VESM-3B
Benign-4.9
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.